References

1. Steinhardt LC, Magill AJ, Arguin PM, , 2011. Review: malaria chemoprophylaxis for travelers to Latin America. Am J Trop Med Hyg 85: 1015–1024.[Crossref] [Google Scholar]
2. Behrens R, Carroll B, Beran J, Bouchaud O, Hellgren U, Hatz C, Jelinek T, Legros F, Mühlberger N, Myrvang B, Siikamäki H, Visser L, TropNetEurop; , 2007. The low and declining risk of malaria in travelers to Latin America: is there still an indication for chemoprophylaxis. Malar J 6: 114.[Crossref] [Google Scholar]
3. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, , 2006. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 75: 402–415. [Google Scholar]
4. Baird JK, Fryauff DJ, Hoffman SL, , 2003. Primaquine for prevention of malaria in travelers. Clin Infect Dis 37: 1659–1667.[Crossref] [Google Scholar]
5. Chen LH, Wilson ME, Schlagenhauf P, , 2007. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 297: 2251–2263.[Crossref] [Google Scholar]
6. Pan American Health Organization, 2010. Report on the Situation of Malaria in the Americas, 2008. Washington, DC: Pan American Health Organization. [Google Scholar]
7. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD, , 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413–431.[Crossref] [Google Scholar]
8. Schlagenhauf P, Petersen E, , 2008. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev 21: 466–472.[Crossref] [Google Scholar]